Anti-RSV Subgroup B Phosphoprotein [4-14]

Immunoblot assays performed in parallel using as antigen 19 clinical RS virus isolates of subgroups A and B (isolated between 1972 and 1984) showed that this antibody reacted only with the phosphoprotein of RS virus subgroup B

Contributors

Inventor Institute
Ayham Alnabulsi Vertebrate Antibodies Limited
Cat. #: 151851
Unit size: 100 ug
Research Fields: Microbiology
Application: ELISA ; IF ; WB
Target: Human Respiratory Syncytial (RS) virus phosphoprotein VP32
Reactivity: Virus
Host: Mouse
Class: Monoclonal
Product description: Immunoblot assays performed in parallel using as antigen 19 clinical RS virus isolates of subgroups A and B (isolated between 1972 and 1984) showed that this antibody reacted only with the phosphoprotein of RS virus subgroup B (Gimenez et al, 1986). RS virus subgroups A and B circulate concurrently in the human population. Infections with RS virus subgroup A are thought to produce more severe disease than infections with RS virus subgroup B. Consequently, it is beneficial for patient management to know early during an RS virus infection whether the patient is infected with RS virus subgroup A or B. Thus, this antibody is relevant for as a diagnostic tool to determine, soon after infection, the specific RS virus subgroup responsible for the RS virus infection. A diagnostic kit protocol is described in Notes.
Conjugation: Unconjugated
Isotype: IgM
Immunogen: The immunogen was gradient-purified RSN-2 virus (subgroup B) that was then treated with 0.1% SDS at 100°C for 2 min. The procedure used to produce this antibody is described in Gimenez et al. (1984).
Myeloma used: P3X63Ag8.653
Target background: Immunoblot assays performed in parallel using as antigen 19 clinical RS virus isolates of subgroups A and B (isolated between 1972 and 1984) showed that this antibody reacted only with the phosphoprotein of RS virus subgroup B (Gimenez et al, 1986). RS virus subgroups A and B circulate concurrently in the human population. Infections with RS virus subgroup A are thought to produce more severe disease than infections with RS virus subgroup B. Consequently, it is beneficial for patient management to know early during an RS virus infection whether the patient is infected with RS virus subgroup A or B. Thus, this antibody is relevant for as a diagnostic tool to determine, soon after infection, the specific RS virus subgroup responsible for the RS virus infection. A diagnostic kit protocol is described in Notes.
Format: Liquid
Concentration: 1mg/ml
Storage buffer: Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine).
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Gimenez et al. 1986. Journal General Virology, 67: 863-70. PMID: 3517224 Gimenez et al. 1984. Journal General Virology, 65: 963-71. PMID: 6202832 Gimenez et al. 1987. Journal General Virology, 68: 1267-75. PMID: 3572364

Images

View Gallery
The antigens used were gradient-purified RSN-2 virus in lanes 1 and 4; partial purified PVM (lane 2) and BRS virus (lane 3). First antibodies

Related Tools for Antibodies

Cat. # Tool Name
151024 Anti-Hairy [1/24] Key Info View Tool
151026 Anti-FCGR1 [10.1] mAb Key Info View Tool
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151033 Anti-HSVUL42 [13C9] Key Info View Tool
151034 Anti-HSVUL42 [13D11] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.